Table 4.
T1w | T2w-FLAIR | T1w Gd | SWI | DWI | Comments | |
---|---|---|---|---|---|---|
CLOCC | Hypointense | Hyperintense | No enhancement | No SWI artifacts | Diffusion restriction | Mostly reversible within a few weeks |
Lymphoma, glioblastoma, metastases | Usually hypointense | Usually hyperintense | Gd enhancement in the majority of cases | Potential intratumoral susceptibility signals or hermorrhagic components | Diffusion restriction depends on the tumor cellularity | Often in line with a mass effect |
Ischemic stroke | Hypointense | Demarcated ischemic tissue hyperintense |
Acute: No enhancement Subacute: Gd enhancement Chronic: No enhancement |
Usually no SWI artifacts, however hemorrhagic transformation possible | Diffusion restriction in acute and subacute cases | T2w-FLAIR hyperintensity not reversible |
MS, ADEM | Hypointense | Hyperintense | Gd enhancement in active lesions | No SWI artifacts | Diffusion restriction might be visible in active lesions | Additional white matter lesions |
Diffuse axonal injury (DAI) of the corpus callosum | Hypointense | Hyperintense | No enhancement | Blood products visible in SWI | Diffusion restriction might be visible in acute lesions | Associated with traumatic brain injury and indicates a poor prognosis |
Marchiafava-Bignami disease | Hypointense | Usually hyperintense | No enhancement | No SWI artifacts | Diffusion restriction | Usually affects the central layers of the corpus callosum. Lesions resolve after successful therapy |
Abbreviations: ADEM acute demyelinating encephalomyelitis, DWI diffusion-weighted imaging, FLAIR fluid-attenuated inversion recovery, Gd gadolinium, MS multiple sclerosis, SWI susceptibility-weighted imaging